On December 19, 2024, Jennifer L. Davis, CEO of Health Care at Procter & Gamble, exercised stock options and disposed of shares in a tax-related transaction. Davis acquired 46.27 shares of Common Stock at $169.79 per share through the exercise of derivative securities.Simultaneously, Davis disposed of an equal number of shares (46.27) at the same price of $169.79, resulting in a total market value of $7,856.18. This transaction was executed to cover tax liabilities associated with the stock option exercise. Following these transactions, Davis directly owns 52,917.7015 shares of Procter & Gamble Common Stock.In addition to her direct holdings, Davis indirectly owns 14,610.8722 shares through a Retirement Plan Trustee. The reported transactions have been completed, with no changes to Davis's overall beneficial ownership position in the company.

On December 19, 2024, Jennifer L. Davis, CEO of Health Care at Procter & Gamble, exercised stock options and disposed of shares in a tax-related transaction. Davis acquired 46.27 shares of Common Stock at $169.79 per share through the exercise of derivative securities.Simultaneously, Davis disposed of an equal number of shares (46.27) at the same price of $169.79, resulting in a total market value of $7,856.18. This transaction was executed to cover tax liabilities associated with the stock option exercise. Following these transactions, Davis directly owns 52,917.7015 shares of Procter & Gamble Common Stock.In addition to her direct holdings, Davis indirectly owns 14,610.8722 shares through a Retirement Plan Trustee. The reported transactions have been completed, with no changes to Davis's overall beneficial ownership position in the company.